KRAS and neoplasm: Much like the KP model in the lung, a mouse strain expressing the mutated Kras G12D in pancreatic ductal cells (LSL-KrasG12D/+;Pdx-1-Cre; KC mice) was developed, resulting in a low tumor load after 5 months (218).